IMPROVED OUTCOMES IN BCG-UNRESPONSIVE BLADDER CANCER PATIENTS WITH NON-INVASIVE DISEASE UNDERGOING BLADDER SPARING THERAPY COMPARED TO T1 DISEASE: RESULTS FROM AN INTERNATIONAL COHORT
Drupad Annapureddy(The University of Texas Southwestern Medical Center), Yair Lotan(Southwestern Medical Center), Peter Black(Southwestern Medical Center), Facundo Davaro(Moffitt Cancer Center), Jeffrey Howard(The University of Texas Southwestern Medical Center), Elizabeth Dyer(Penn State Milton S. Hershey Medical Center), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Stephen Harrington(Queensland University of Technology), Jacob Taylor(Southwestern Medical Center), M. Roumiguié(Institut universitaire du cancer de Toulouse Oncopole), Michael J. O’Donnell(University of Iowa), Ian M. McElree(Vanderbilt University Medical Center), Roger Li(Unknown), Gary D. Steinberg(Rush University Medical Center), William C. Huang(NYU Langone Health), Anna J. Black(University of British Columbia), Pratik Kanabur(Carilion Clinic), Wei Shen Tan, Solomon L. Woldu(The University of Texas Southwestern Medical Center), Vignesh T. Packiam(Rutgers, The State University of New Jersey), Jay D. Raman(Penn State Milton S. Hershey Medical Center), Kendrick Yim(Brigham and Women's Hospital), Mark A. Preston(Brigham and Women's Hospital), Seth Lerner(Baylor College of Medicine)
Urologic Oncology Seminars and Original Investigations
February 27, 2025
Cited by 0
Related Papers
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
|Nature Genetics|2014|359